Latest bladder cancer Stories
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the U.S.
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
Researchers released some pretty incredible findings last week about cancer. In a multiple institute study, researchers looked closely at how cancers are classified.
Takeda Pharmaceuticals Co. and Eli Lilly & Co.
The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform
BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB)
Micromedic to continue developing its CellDetect® technology for monitoring the recurrence of bladder cancer TEL AVIV, Israel, July 1, 2014 /PRNewswire/ -- BioLight
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation.